Diagnostics
Seno Medical’s Next-Generation Imagio Imaging System Receives EU MDR CE Mark Certification
Seno Medical; Imagio Imaging System; EU MDR CE Mark; opto-acoustic imaging; breast cancer diagnostics; Model 9100
Scaling for a New Era: The Rise of Radiopharma
radiopharmaceuticals; radioligand therapy; oncology; precision oncology; targeted alpha therapy; Lutetium-177; Actinium-225; clinical trials; radiotheranostics; M&A; biotech funding; supply chain; infrastructure; CROs; companion diagnostics
Recent advances in AI for antimicrobial resistance (AMR) prevention and control
antimicrobial resistance; AI in healthcare; machine learning; antibiotic stewardship; AI antibiotic discovery; phage therapy; rapid diagnostics; AMR surveillance; generative AI
Mindpeak Secures First Patent for Advanced AI Method in Digital Pathology
Mindpeak; digital pathology; AI-powered pathology; oncology diagnostics; cell classification; histopathology; EU patent; United Kingdom validation; AI model training; precision diagnostics
Synbio International Inc. Expands Its Board of Directors and Strengthens Clinical Leadership
Synbio International Inc.; board of directors; Nick Vatakis; Desiree Cain; Medical Director; Chief Financial Officer; clinical trial; AI-driven diagnostics
Transforming Patient Data into Therapeutic Breakthroughs in 2025
AI diagnostics; Digital therapeutics; Personalized medicine
Roche’s Top Three Ambition in Obesity Not Dependent on a Single Megablockbuster
Roche; obesity strategy; ecosystem approach; pharmaceuticals; diagnostics; digital health; cardiometabolic care; portfolio diversification; weight-loss drugs
Validated Devices for Easy Self-Collection and Stabilization of Vaginal Microbiome Samples: Recent News and Advances
vaginal microbiome; self-collection devices; sample stabilization; diagnostics; metagenomic sequencing; clinical reproducibility
Advancements in Predicting Tumor Response and Expanding Therapy Eligibility Using Epigenomic Biomarkers
epigenomic biomarkers; tumor response prediction; personalized cancer therapy; DNA methylation; AI-driven diagnostics
ASCO25 Primer: Navigating Cancer R&D Amid Regulatory Uncertainty
ASCO25; cancer research; oncology; regulatory uncertainty; immunotherapy; precision medicine; diagnostics; expert perspectives; policy changes